Clinical Pipeline

 OncoSec Clinical Program Pipeline

ImmunoPulse Program Phase I Phase IIa Phase IIb Phase III Registration Trial
Metastatic Melanoma
Melanoma Combination Study
IL-12 + Anti-PD-1 (KEYTRUDA®)
Head & Neck Cancer
Triple Negative Breast Cancer

Completed:

In Progress:

Enrollment for clinical trials is currently underway. For further information about available trials, Learn More

Top

Download our Investor Overview:

* indicates required field

Subscribe to Our Newsletter:


Be the first to hear about new progress and breakthroughs at OncoSec.